🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05770661
Recruiting Observational

China Children Eye Study

NCT05770661 · tracked via the Priya Life Science China tracker
Sponsor
Shanghai Eye Disease Prevention and Treatment Center
Phase
Observational
Started
2023-03-10
Last updated
2026-08-07

Condition(s) studied

Axial LengthMyopiaChild Development

Study summary

The primary objective of this multi-center, observational study is to establish the reference ranges of axial length in Chinese children and adolescents.

30,000 children aged 3-18 years were examined with cycloplegia to collect their ocular parameters and were all followed up for three years with annual visits.

Eligibility

Sex
ALL
Min age
3 Years
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 3 to 18 years * Have been lived in the research areas for at least one year, and will not move to other places in the following two years * Parents or guardians sign an informed consent form, and children over 6 years old need oral consent to participate Exclusion Criteria: * Mental diseases, unable to cooperate to complete the eye assessment * Ophthalmic diseases, inability to cooperate to complete the inspection

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Shanghai Eye Disease Prevention & Treatment Center Shanghai Shanghai Municipality Recruiting
Shanghai Eye Disease Prevention and Treatment Center Shanghai China Recruiting

More Shanghai Eye Disease Prevention and Treatment Center trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05770661 on ClinicalTrials.gov ↗ ← All trials in China